A Review on Proniosomes as a Novel Drug Delivery System.
INTERNATIONAL JOURNAL OF DRUG DELIVERY TECHNOLOGY · 25.09.2024 · 14 (03) · 1931-1935
DOI: 10.25258/ijddt.14.3.93 ↗Kurz gefasst
Fachartikel in der Zeitschrift INTERNATIONAL JOURNAL OF DRUG DELIVERY TECHNOLOGY, online erschienen am 25.09.2024. Verfasst von Prasanthi . Pakalapati und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Proniosomes are desiccated versions of surfactant-coated, water-soluble carrier particles. Before usage, on agitation in heated aqueous solution, they are rehydrated in a matter of minutes to create niosomal dispersion. In storage and transit, proniosomes maintain their physical stability. The drug contained within the proniosomes’ vesicular structure increases the drug’s potency, improves its absorption into the target tissue, and lowers its toxicity. Niosomes are technically more promising than liposomes as drug carriers since they are more chemically stable and don’t have many of the glitches of liposomes, like high cost and problems with phospholipid purity. Focusing on proniosome preparation, characterization, and application in targeted drug delivery, this study highlights their general approaches.
Zitieren
APA
Pakalapati, P., & Varma, M. M. (2024). A Review on Proniosomes as a Novel Drug Delivery System. INTERNATIONAL JOURNAL OF DRUG DELIVERY TECHNOLOGY, 14(03), 1931-1935. https://doi.org/10.25258/ijddt.14.3.93
Vancouver
Pakalapati P, Varma MM. A Review on Proniosomes as a Novel Drug Delivery System. INTERNATIONAL JOURNAL OF DRUG DELIVERY TECHNOLOGY. 2024;14(03):1931-1935. doi:10.25258/ijddt.14.3.93
BibTeX
@article{Pakalapati2024,
author = {Pakalapati, Prasanthi . and Varma, Manthina Mohan},
title = {A Review on Proniosomes as a Novel Drug Delivery System},
journal = {INTERNATIONAL JOURNAL OF DRUG DELIVERY TECHNOLOGY},
year = {2024},
volume = {14},
number = {03},
pages = {1931--1935},
doi = {10.25258/ijddt.14.3.93}
}
EUVIMED